GKCC, LLC 4
4 · Elicio Therapeutics, Inc. · Filed Jul 2, 2024
Insider Transaction Report
Form 4
Chudnovsky Yekaterina
Director10% Owner
Transactions
- Purchase
Common Warrants
2024-06-28+1,600,000→ 1,600,000 totalExercise: $5.00→ Common Stock (1,600,000 underlying) - Purchase
Pre-Funded Warrants
2024-06-28$4.99/sh+1,600,000$7,984,000→ 1,600,000 totalExercise: $0.01→ Common Stock (1,600,000 underlying)
Footnotes (4)
- [F1]Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%.
- [F2]The Common Warrants expire on July 1, 2029.
- [F3]Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%.
- [F4]The Pre-Funded Warrants do not have an expiration date.